Food News and Research

RSS

FSMB takes effort to educate physicians on safe prescribing of opioid analgesics

The Federation of State Medical Boards (FSMB) announced today that the nation's state medical boards have kicked off a multi-state effort to educate health care professionals on the safe and responsible prescribing of extended-release (ER) and long-acting (LA) opioid analgesics for patients with chronic pain.

4 Aug 2014

Banning vending machines from schools does not reduce soda consumption among students

Banning vending machines from schools can actually increase soda and fast food consumption among students if it's the only school food policy change implemented, according to research conducted at the University of Illinois at Chicago.

4 Aug 2014

Study shows that mice can identify specific odors amid complex olfactory environments

For many animals, making sense of the clutter of sensory stimuli is often a matter or literal life or death. Exactly how animals separate objects of interest, such as food sources or the scent of predators, from background information, however, remains largely unknown.

4 Aug 2014

First Edition: August 1, 2014

Today's headlines include more questions about how healthcare.gov will function during the next open enrollment period.

1 Aug 2014

Viewpoints: GOP lawsuit against Obama on health law is not a 'stunt'; 'wisdom' lacking in the House; the danger of cyberattacks on hospitals

"So sue me" is President Obama's message to Congress. And on Wednesday the House of Representatives took up his taunt, authorizing a lawsuit to challenge the president's failure to faithfully execute provisions of the Affordable Care Act as passed by Congress. The House lawsuit is no "stunt," as Mr. Obama has characterized it.

1 Aug 2014

Longer looks: Pittsburgh's 'frayed safety net'; feeding hungry kids in the summer; curing cancer

More than a quarter of the hospitals in the Pittsburgh area closed in the first decade of the 21s century, drastically reducing the amount of charitable care available to the poor.

1 Aug 2014

Tips from ACAAI to help kids enjoy healthy, symptom-free days in classroom

Your kids may be enjoying the lazy days of summer, but if they have asthma, allergies, or both, they need to be prepared for back-to-school. And so do their classrooms. More than 10 million kids under age 18 have asthma, and 11 percent suffer from respiratory allergies. About 6 percent have also been diagnosed with food allergies.

1 Aug 2014

Botanical Dietary Supplement Screening using NMR and MS

An interview with Kim Colson from Bruker Biospin, discussing the applications of NMR and mass spectrometry in the field of botanical science.

From Bruker BioSpin Division 1 Aug 2014

Consumer education campaign can help explain eventual changes to food labels

To help Americans make better decisions about what they eat, the Food and Drug Administration (FDA) earlier this year proposed significant changes to the Nutrition Facts label found on nearly every food product in the U.S.

31 Jul 2014

ChromaDex to provide Murdoch Childrens Research Institute with NR ingredient for research use

ChromaDex Corp., an innovative natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today it has entered into a material transfer agreement (MTA) with Murdoch Childrens Research Institute, the preeminent child health research institute in Australia.

31 Jul 2014

Scientists study how artificial light influences biological clock

Researchers at Inserm, led by Claude Gronfier (Inserm Unit 846: Stem Cell and Brain Institute), have, for the first time, conducted a study under real conditions on the body clocks of members of the international polar research station Concordia.

31 Jul 2014

Regeneron announces FDA approval of EYLEA Injection for DME treatment

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

31 Jul 2014

Obesity mutation MC4R can significantly contribute to weight gain at early age

People who have the most common genetic mutation linked to obesity respond differently to pictures of appetizing foods than overweight or obese people who do not have the genetic mutation, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

31 Jul 2014

Nelipak completes acquisition of Flexpak

Nelipak Corporation announced today that it has closed on the acquisition of Debond Corporation.

30 Jul 2014

Researchers establish new strategy to help surgeons see entire tumor in patient

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

30 Jul 2014

Do we take liquid calories into account when planning meals?

New research by academics in the University of Bristol's Nutrition and Behaviour Unit (NBU) has looked into whether we take liquid calories into account when planning meals.

30 Jul 2014

Children's favorite foods can pose choking hazards

Most parents never dream that their children's favorite foods can pose choking hazards. It happened to Landon Jones when he was 15 months old. He was walking around eating a handful of nuts when a cashew became lodged in his bronchi (wind passage to his lung) causing wheezing and coughing.

30 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.

From Quest Diagnostics 29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014